Margarita Majem

ScholarGPS® ID: 51753142611123

Affiliation

Hospital de la Santa Creu i Sant Pau, Spain

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

251

Predicted Citations

17,667

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
KROCUS: A phase II study investigating the efficacy and safety of fulzerasib (GFH925) in combination with cetuximab in patients with previously untreated advanced KRAS G12C mutated NSCLC. (journal article) Gregorc, Vanesa \| González-Cao, Maria \| Salvagni, Stefania \| Koumarianou, Anna \| Gil-Bazo, Ignacio \| Maio, Michele \| Viteri, Santiago \| Majem, Margarita \| Gutiérrez, Vanesa \| Bernabe Caro, Reyes \| ... \| Rosell, Rafael Journal of Clinical Oncology, volume 42, issue 17_suppl, pages LBA8511-LBA8511 (2024). 10.1200/JCO.2024.42.17_suppl.LBA8511 Cited by (1) \| Cite \| Source
Updated results from COAST, a phase 2 study of durvalumab (D) ± oleclumab (O) or monalizumab (M) in patients (pts) with stage III unresectable non-small cell lung cancer (uNSCLC). (journal article) Aggarwal, Charu \| Martinez-Marti, Alex \| Majem, Margarita \| Barlesi, Fabrice \| Carcereny, Enric \| Chu, Quincy S. \| Monnet, Isabelle \| Sanchez, Alfredo \| Dakhil, Shaker R. \| Camidge, David Ross \| ... \| Herbst, Roy S. Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 8046-8046 (2024). 10.1200/JCO.2024.42.16_suppl.8046 Cited by (1) \| Cite \| Source
Kinetics of IFNγ-Induced Cytokines and Development of Immune-Related Adverse Events in Patients Receiving PD-(L)1 Inhibitors (journal article) Alserawan, Leticia \| Mulet, Maria \| Anguera, Geòrgia \| Riudavets, Mariona \| Zamora, Carlos \| Osuna-Gómez, Rubén \| Serra-López, Jorgina \| Barba Joaquín, Andrés \| Sullivan, Ivana \| Majem, Margarita \| Vidal, Silvia Cancers, volume 16, issue 9, pages 1759- (2024). 10.3390/cancers16091759 Cite \| Source
Potential Role of Circulating PD-L1+ Leukocytes as a Predictor of Response to Anti-PD-(L)1 Therapy in NSCLC Patients (journal article) Anguera, Georgia \| Mulet, Maria \| Zamora, Carlos \| Osuna-Gómez, Rubén \| Barba, Andrés \| Sullivan, Ivana \| Serra-López, Jorgina \| Cantó, Elisabet \| Vidal, Silvia \| Majem, Margarita Biomedicines, volume 12, issue 5, pages 958- (2024). 10.3390/biomedicines12050958 Cite \| Source
Understanding health-related quality of life measures used in early-stage non-small cell lung cancer clinical trials: A review (journal article) Majem, Margarita \| Basch, Ethan \| Cella, David \| Garon, Edward B. \| Herbst, Roy S. \| Leighl, Natasha B. Lung Cancer, volume 187 (2024). 10.1016/j.lungcan.2023.107419 Cite \| Source
12P Spatially preserved multi-region transcriptomic subtyping and biomarkers associated with long-term benefit with chemoimmunotherapy in extensive-stage small cell lung cancer (ES-SCLC) (journal article) Peressini, M. \| Cubells, C. Martí \| Calderon, V. Gutierrez \| Sureda, B. Massuti \| Majem, M. \| García-Campelo, M.R. \| Tain, P. Diz \| Isla Casado, M.D. \| Paul, A. Moreno \| Navalon, F.J. Garcia \| ... \| Zugazagoitia, J. Immuno-Oncology and Technology, volume 20 (2023). 10.1016/j.iotech.2023.100482 Cite \| Source
595 Biomarker results from the 1st line non-small cell lung cancer cohort of TACTI-002: pharmacodynamic effects of combining eftilagimod alpha (soluble LAG-3) and pembrolizumab (conference) Forster, Martin \| Felip, Enriqueta \| Majem, Margarita \| Doger, Bernard \| Clay, Tim \| Carcereny, Enric \| Bondarenko, Igor \| Peguero, Julio \| Dols, Manuel Cobo \| Ursol, Grygorii \| ... \| Triebel, Frederic SITC 38th Annual Meeting (SITC 2023) Abstracts (2023) 10.1136/jitc-2023-SITC2023.0595 Cite \| Source
MA20.09 Baseline PD-L1+ Neutrophils and Monocytes Predict Radiological Response to Anti-PD-(L)1 Therapy in Patients with Advanced NSCLC (journal article) Majem, M. \| Mulet, M. \| Anguera, G. \| Osuna, R.Q. \| Barba, A. \| Canto, E. \| Serra, J. \| Alejandre, J. \| Sullivan, I. \| Martinez, S. \| Vidal, S. Journal of Thoracic Oncology, volume 18, issue 11, pages S176- (2023). 10.1016/j.jtho.2023.09.266 Cite \| Source
1090P Outcome impact of time from complete resection to start of adjuvant immunotherapy in stage III-IV melanoma patients (journal article) Martinez Recio, S. \| Molina Pérez, M.A. \| Muñoz Couselo, E. \| Sevillano Tripero, A.R. \| Martin-Liberal, J. \| Orrillo, M. \| Arance Fernandez, A.M. \| Aya Moreno, F. \| Fernández-Morales, L.A. \| Quindos Varela, M. \| ... \| Majem, M. Annals of Oncology, volume 34 (2023). 10.1016/j.annonc.2023.09.2224 Cite \| Source
Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer (journal article) Nadal, Ernest \| Oré-Arce, Martín \| Remon, Jordi \| Bernabé-Caro, Reyes \| Covela-Rúa, Marta \| de Castro-Carpeño, Javier \| Massutí-Sureda, Bartomeu \| Guillot-Morales, Mónica \| Majem, Margarita \| Maestu-Maiques, Inmaculada \| ... \| Gironés, Regina Clinical and Translational Oncology, volume 25, issue 11, pages 3139-3151 (2023). 10.1007/s12094-023-03286-3 Cited by (2) \| Cite \| Source
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer (journal article) Wakelee, Heather \| Liberman, Moishe \| Kato, Terufumi \| Tsuboi, Masahiro \| Lee, Se-Hoon \| Gao, Shugeng \| Chen, Ke-Neng \| Dooms, Christophe \| Majem, Margarita \| Eigendorff, Ekkehard \| ... \| Spicer, Jonathan D. New England Journal of Medicine, volume 389, issue 6, pages 491-503 (2023). 10.1056/NEJMoa2302983 Cited by (249) \| Cite \| Source
PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement (journal article) Isla, Dolores \| Sánchez, Alfredo \| Casal, Joaquín \| Cobo, Manuel \| Majem, Margarita \| Reguart, Noemi \| Zugazagoitia, Jon \| Bernabé, Reyes Journal of Clinical Medicine, volume 12, issue 15, pages 5063- (2023). 10.3390/jcm12155063 Cited by (1) \| Cite \| Source
The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium (journal article) Viñolas, Nuria \| Mezquita, Laura \| Corral, Jesús \| Cobo, Manuel \| Gil-Moncayo, Francisco \| Paz-Ares, Luis \| Remon, Jordi \| Rodríguez, María \| Ruano-Raviña, Alberto \| Conde, Esther \| ... \| de Castro, Javier Clinical and Translational Oncology, volume 26, issue 2, pages 352-362 (2023). 10.1007/s12094-023-03262-x Cite \| Source
Multicenter analysis of melanoma recurrence pattern and management after adjuvant immunotherapy. (journal article) Martínez Recio, Sergio \| Molina, Maria Alejandra \| Muñoz-Couselo, Eva \| Sevillano Tripero, Alberto Rafael \| Martin-Liberal, Juan \| Orrillo, Mayra \| Fernandez, Luis Antonio \| Quindós Varela, Maria \| Lesta, Rocio \| Barba, Andrés \| ... \| Majem, Margarita Journal of Clinical Oncology, volume 41, issue 16_suppl, pages e21573-e21573 (2023). 10.1200/JCO.2023.41.16_suppl.e21573 Cite \| Source
Final results from TACTI-002 Part C: A phase II study of eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab in patients with metastatic 2nd line head and neck squamous cell carcinoma unselected for PD-L1. (journal article) Doger de Spéville, Bernard \| Felip, Enriqueta \| Forster, Martin \| Majem, Margarita \| Bajaj, Pawan \| Peguero, Julio Antonio \| Carcereny, Enric \| Krebs, Matthew G \| Mukherjee, Uma \| Mueller, Christian \| Triebel, Frederic Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 6029-6029 (2023). 10.1200/JCO.2023.41.16_suppl.6029 Cited by (4) \| Cite \| Source
Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2–IA3 EGFR-Mutated NSCLC: ADAURA2 (journal article) Tsutani, Yasuhiro \| Goldman, Jonathan W. \| Dacic, Sanja \| Yatabe, Yasushi \| Majem, Margarita \| Huang, Xiangning \| Chen, Allen \| van der Gronde, Toon \| He, Jie Clinical Lung Cancer, volume 24, issue 4, pages 376-380 (2023). 10.1016/j.cllc.2023.02.002 Cited by (17) \| Cite \| Source
P062 - EVALUACIÓN DE LA RESPUESTA PRECOZ A LA INMUNOTERAPIA CON PEMBROLIZUMAB EN PACIENTES CON MUTACIÓN PD-L1 Y SOSPECHA DE SEUDOPROGRESIÓN (PROGRESIÓN NO CONFIRMADA) (journal article) Mormandi, Patricia Stefaneli \| Cascon, Aida Piedra \| Torres, Paula \| Camacho, Valle \| León, Alejandro Fernández \| Barba, A. \| Duch, Joan \| Majem, Margarita \| Flotats, Albert Revista Española de Medicina Nuclear e Imagen Molecular, volume 42 (2023). 10.1016/S2253-654X(23)00182-8 Cite \| Source
PO-1303 Fractionated stereotactic radiation therapy for brain metastases: Outcomes and patterns of failure (journal article) Farre, N. \| Soto-Cambres, A.M. \| Rabi, S. \| Jornet, N. \| Balart, J. \| Vila, A. \| Rojas, J.V. \| Otero, E. \| Majem, M. \| Sullivan, I. \| ... \| Sancho-Pardo, G. Radiotherapy and Oncology, volume 182 (2023). 10.1016/S0167-8140(23)66218-8 Cite \| Source
11MO Final data from a phase II study (TACTI-002) of eftilagimod alpha (soluble LAG-3) and pembrolizumab in 2nd-line metastatic NSCLC pts resistant to PD-1/PD-L1 inhibitors (journal article) Majem, M. \| Forster, M.D. \| Krebs, M.G. \| Peguero, J. \| Clay, T.D. \| Felip, E. \| Iams, W. \| Roxburgh, P. \| de Spéville, B. Doger \| Bajaj, P. \| ... \| Triebel, F. Journal of Thoracic Oncology, volume 18, issue 4, pages S43-S44 (2023). 10.1016/S1556-0864(23)00265-4 Cited by (4) \| Cite \| Source
Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer (journal article) Chmielecki, Juliann \| Gray, Jhanelle E. \| Cheng, Ying \| Ohe, Yuichiro \| Imamura, Fumio \| Cho, Byoung Chul \| Lin, Meng-Chih \| Majem, Margarita \| Shah, Riyaz \| Rukazenkov, Yuri \| ... \| Ramalingam, Suresh S. Nature Communications, volume 14, issue 1 (2023). 10.1038/s41467-023-35961-y Cited by (54) \| Cite \| Source